COVISCREEN is a reliable and innovative rapid diagnostic test designed to detect total antibodies (IgM, IgA, and IgG) specific to the SARS-CoV-2 virus in human serum, plasma, or whole blood samples. Based on a unique double-antigen immunoassay principle, this test uses advanced immunochromatography technology for qualitative and accurate results.

The test membrane is predispensed with SARS-CoV-2 virus-specific recombinant antigens, streptavidin-gold conjugates, and biotinylated BSA as an internal control to ensure precision and reliability.

Key Features:

• Detects total antibodies (IgM + IgA + IgG) to SARS-CoV-2

• Double-antigen immunoassay for improved sensitivity

• Works with serum, plasma, or whole blood samples

• Rapid results within 20 minutes

• Easy-to-use, no special equipment required

• Shelf life of 18 months at 4–30°C

• Ideal for hospitals, labs, and diagnostic centers

COVISCREEN provides a fast, accurate, and convenient solution for COVID-19 antibody detection, making it a valuable tool for widespread screening and monitoring.